Medical marketing news, white papers, reports, and events from PharmaLeaders. New content daily, on our website and delivered right to your inbox.
Which is Bigger: Pharma Profits or R&D Spending? On Mar 27, 2017, Public Citizen came out with a report that claimed “Pharmaceutical Industry Profits Are Nearly Double R&D Costs in 2013, 2014 and 2015”. The email announcing the report said “Even the inflated estimates of R&D reported by the industry are dwarfed by the industry’s profits, which, for the 20 largest pharmaceutical companies, ... Read More
The Context Problem Foils Pharma Online Advertising Click on image to enlarge. Last week I came across an article about Johnson & Johnson and other pharma companies pulling their ads from Youtube because they appeared adjacent to hate speech, e.g.; an anti-Semitic clip claiming the existence of a “Jewish World Order” (see the back story embedded at the end of this post or ... Read More
Vitals Index Study Reveals Stark Generational Differences When It Comes to Attitudes About Health Care Millennials have a high-degree of trust; Gen Xers are the most skeptical A national survey released today by Vitals found that, when it comes to attitudes about health care, a lot may depend on your age. Separated by decades, generations are often defined by researchers in their own unique terms. Now, a Vitals Index study that surveyed ... Read More
The Great DTC Shake-Up Patient perspectives on direct-to-consumer advertising This in-depth eyeforpharma whitepaper, which we developed with Health Perspectives Group explores the evolving role of DTC advertising with direct feedback from patient’s – including exclusive results from the recent “DTC Attitudes, Behaviours and Preferences” patient study conducted by Health Stories Project – Insights, (HSPi). Read More
GSK’s New “Ethical” Customer Approach: Is it Delivering? Will GSK’s new ‘ethical’ approach to its customers deliver commercial success? This is the question eyeforpharma answers in its latest whitepaper on GSK’s radical new customer engagement model. Read the full paper here: GSK’s New “Ethical” Customer Approach: Is it Delivering? Read More